In March 2025, the company announced new programs for just a immediate-to-client providing of its Wegovy weight loss drug. The company recognized a brand new pharmacy, identified as NovoCare, which might charge shoppers $499 monthly for access to the drug, under 50 percent the expense of the drug through other pharmaceutical distribution networks.[